A low-fat diet improves fatigue in multiple sclerosis: Results from a randomized controlled trial.

Background: Fatigue can be a disabling multiple sclerosis (MS) symptom with no effective treatment options.

Objective: Determine whether a low-fat diet improves fatigue in people with MS (PwMS).

Methods: We conducted a 16-week randomized controlled trial (RCT) and allocated PwMS to a low-fat diet (active, total daily fat calories not exceeding 20%) or wait-list (control) group.

Vascular disease risk factors in multiple sclerosis: Effect on metabolism and brain volumes.

Background: Vascular disease risk factors (VDRF) such as hypertension, hyperlipidemia, obesity, diabetes and heart disease likely play a role in disease progression in people with multiple sclerosis (PwMS) (Marrie, Rudick et al. 2010). Studies exploring the mechanistic connection between vascular disease and MS disease progression are scant.

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial.

Background: Lipoic acid, an antioxidant, has beneficial effects in experimental acute optic neuritis and autoimmune encephalomyelitis. Optical coherence tomography can detect retinal nerve fiber layer thinning, representing axonal degeneration, approximately 3-6 months after acute optic neuritis.

Objective: To determine whether lipoic acid is neuroprotective in acute optic neuritis.

Correction to: Dietary Interventions and Multiple Sclerosis.

The original version of this article contains an error in the second sentence of the second paragraph of the Paleolithic Diet section.

Dietary Interventions and Multiple Sclerosis.

Multiple Sclerosis (MS) is a chronic, disabling neurologic disease that has its onset in young adulthood. While the knowledge about underlying pathogenesis of MS has improved significantly over the last few decades, the exact cause still eludes us. Despite the availability of several United States Food and Drug Administration-approved disease-modifying therapies (DMT) for MS in the last two decades, the disease remains disabling for many.